Otros idiomas LeMaitre Vascular, Inc.

Acciones

Tiempo real estimado Cboe BZX Otros sitios de cotización 16:50:39 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
65,2 ^USD	-1,57 %		+1,85 %	+15,25 %

26/04	LEMAITRE VASCULAR, INC. : Stifel Nicolaus tiene una opinión positiva	ZM
12/03	Insider de Lemaitre Vascular vendió acciones por valor de 309.684 dólares, según un reciente registro de la SEC	MT

North American Morning Briefing : Investors Brace -2-	29/04
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024	22/04
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024	19/04
LeMaitre Vascular : Proxy Statement for 2024 Annual Meeting	16/04
LeMaitre Vascular : Proxy Card for 2024 Annual Meeting	16/04
LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference	26/03
Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing	12/03
Lemaitre Vascular Insider Sold Shares Worth $344,925, According to a Recent SEC Filing	07/03
Lemaitre Vascular Insider Sold Shares Worth $517,500, According to a Recent SEC Filing	07/03
LeMaitre to Participate at Upcoming Investor Conferences in March	01/03
Health Care Drops After Mixed Earnings -- Health Care Roundup	28/02
LeMaitre: Q4 Earnings Snapshot	27/02
LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on March 28, 2024	27/02
LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	27/02
LeMaitre Vascular, Inc. announces an Equity Buyback for $50 million worth of its shares.	27/02
LeMaitre Vascular, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
(LMAT) LEMAITRE VASCULAR Forecasts Fiscal Year 2024 EPS $1.65	27/02
(LMAT) LEMAITRE VASCULAR Expects Q1 EPS $0.28	27/02
Earnings Flash (LMAT) LEMAITRE VASCULAR Reports Q4 Revenue $48.9M, vs. Street Est of $49M	27/02
LeMaitre Q4 2023 Financial Results	27/02

No hay resultados para esta búsqueda